• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀壳聚糖纳米粒的配方设计用于骨再生的控制释放:Box-Behnken 设计优化、稳定性和体内研究。

Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr el Aini Street, Cairo, Egypt.

Department of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University, Kasr Al Aini Street, Cairo, Egypt.

出版信息

Int J Pharm. 2020 Mar 15;577:119038. doi: 10.1016/j.ijpharm.2020.119038. Epub 2020 Jan 15.

DOI:10.1016/j.ijpharm.2020.119038
PMID:31953085
Abstract

This study aims to formulate and optimize simvastatin loaded chitosan-tripolyphosphate nanoparticles (SIM CS-TPP NPs) using ionic gelation method to provide a local delivery system that controls and sustains the release of simvastatin in the desired dose to promote bone regeneration. Box-Behnken design was adopted for optimization of the formulation variables of the prepared nanoparticles namely, CS percentage, TPP percentage and homogenization time. The optimized formula was selected and characterized by transmission electronic microscopy, in-vitro release, swelling index and storage stability. The ability of the optimum formula to stimulate bone regeneration upon implantation in bone defect generated in rabbits was also evaluated. The optimum SIM CS-TPP NPs had particle size of 106 nm, zeta potential of 43.3 mv, polydispersity index of 0.295 and entrapment efficiency of 98.78% and also showed good storage stability over the first month in addition to controlled and steady release over 2 weeks that effectively delivered simvastatin in a therapeutic dose needed for bone regeneration. Cone beam computed tomography 3D images, bone density measurements and histopathological analysis confirmed the high potential of SIM CS-TPP NPs in promoting bone regeneration in the generated defects compared to both the non-medicated formula and untreated groups after 6 weeks of implantation.

摘要

本研究旨在通过离子凝胶法制备和优化载辛伐他汀壳聚糖-三聚磷酸酯纳米粒(SIM CS-TPP NPs),提供一种局部递送系统,以控制和维持所需剂量的辛伐他汀释放,从而促进骨再生。采用 Box-Behnken 设计对所制备纳米粒的处方变量(CS 百分比、TPP 百分比和均质时间)进行优化。选择并通过透射电子显微镜、体外释放、溶胀指数和储存稳定性对优化配方进行表征。还评估了最优配方在兔骨缺损中植入后刺激骨再生的能力。最优的 SIM CS-TPP NPs 的粒径为 106nm,Zeta 电位为 43.3mV,多分散指数为 0.295,包封效率为 98.78%,并且在最初一个月内具有良好的储存稳定性,此外,还能在 2 周内实现持续、稳定的释放,有效递送到促进骨再生所需的治疗剂量的辛伐他汀。锥形束 CT 3D 图像、骨密度测量和组织病理学分析证实,与未载药配方和未处理组相比,SIM CS-TPP NPs 在植入 6 周后,在生成的缺陷中具有更高的促进骨再生潜力。

相似文献

1
Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.辛伐他汀壳聚糖纳米粒的配方设计用于骨再生的控制释放:Box-Behnken 设计优化、稳定性和体内研究。
Int J Pharm. 2020 Mar 15;577:119038. doi: 10.1016/j.ijpharm.2020.119038. Epub 2020 Jan 15.
2
Investigating the bone regeneration activity of PVA nanofibers scaffolds loaded with simvastatin/chitosan nanoparticles in an induced bone defect rabbit model.在诱导性骨缺损兔模型中研究负载辛伐他汀/壳聚糖纳米颗粒的聚乙烯醇纳米纤维支架的骨再生活性。
Int J Biol Macromol. 2022 Dec 1;222(Pt B):2399-2413. doi: 10.1016/j.ijbiomac.2022.10.026. Epub 2022 Oct 8.
3
In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.壳聚糖包载辛伐他汀纳米粒原位凝胶:一种有前途的给药系统,可有效抑制舌癌细胞增殖。
Mar Drugs. 2020 Apr 9;18(4):201. doi: 10.3390/md18040201.
4
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.载利培酮壳聚糖纳米粒的鼻腔给药制剂及生物药剂学评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1342-1350. doi: 10.1080/03639045.2019.1619759. Epub 2019 Jun 3.
5
Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.壳聚糖纳米粒增强难溶性卡维地洛的口服生物利用度:优化及药代动力学研究。
Int J Biol Macromol. 2019 Aug 15;135:246-260. doi: 10.1016/j.ijbiomac.2019.05.162. Epub 2019 May 23.
6
Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: , and evaluation.壳聚糖-TPP 纳米粒经泊洛沙姆稳定用于控制甲磺酸多沙唑嗪的释放和提高其生物利用度:制备、表征、和 评价。
Drug Dev Ind Pharm. 2019 Jul;45(7):1130-1139. doi: 10.1080/03639045.2019.1597105. Epub 2019 May 3.
7
In vitro and in vivo evaluation of chitosan scaffolds combined with simvastatin-loaded nanoparticles for guided bone regeneration.壳聚糖支架联合载辛伐他汀纳米粒的体内外评价及其在引导骨再生中的应用。
J Mater Sci Mater Med. 2019 Apr 12;30(4):47. doi: 10.1007/s10856-019-6249-3.
8
Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.应用 Box-Behnken 实验设计,制备并优化载硒蛋氨酸壳聚糖纳米粒,并用玉米醇溶蛋白进行包被,用于口服递药。
Int J Pharm. 2018 Nov 15;551(1-2):257-269. doi: 10.1016/j.ijpharm.2018.08.050. Epub 2018 Aug 25.
9
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
10
Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.载雷洛昔芬壳聚糖纳米粒的制备、研制与优化及其在骨质疏松治疗中的应用。
Drug Deliv. 2015;22(6):823-36. doi: 10.3109/10717544.2014.900153. Epub 2014 Apr 14.

引用本文的文献

1
Innovative pH-responsive alginate-coated rosuvastatin-loaded chitosan nanoparticles: a targeted approach to inhibiting HMGB1-activated RAGE/TLR4-NFκB signaling in colonic inflammation in rats.创新性pH响应性海藻酸盐包被的载瑞舒伐他汀壳聚糖纳米粒:一种抑制大鼠结肠炎症中HMGB1激活的RAGE/TLR4-NFκB信号传导的靶向方法。
Front Pharmacol. 2025 Jun 18;16:1546010. doi: 10.3389/fphar.2025.1546010. eCollection 2025.
2
Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia.基于壳聚糖的纳米颗粒靶向递送系统:在血脂异常治疗方法中的应用
Int J Nanomedicine. 2025 May 24;20:6611-6636. doi: 10.2147/IJN.S517492. eCollection 2025.
3
Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis.
利用纳米科学与战略交付推动骨质疏松症研究进展
AAPS PharmSciTech. 2025 May 9;26(5):129. doi: 10.1208/s12249-025-03120-9.
4
Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration.他汀类药物对骨代谢影响的分子机制:骨再生中他汀类药物递送方式的不断演变模式。
Pharmacol Rep. 2025 Jun;77(3):624-644. doi: 10.1007/s43440-025-00716-7. Epub 2025 Apr 1.
5
Simvastatin modulates osteogenic differentiation in Stem Cells isolated from Apical Papilla.辛伐他汀调节从根尖乳头分离的干细胞的成骨分化。
BMC Oral Health. 2025 Mar 18;25(1):398. doi: 10.1186/s12903-025-05721-z.
6
Quality-by-design-engineered mitochondrial targeted nanoparticles for glioblastoma therapy.用于胶质母细胞瘤治疗的质量源于设计的工程化线粒体靶向纳米颗粒
RSC Adv. 2024 Oct 28;14(46):34100-34118. doi: 10.1039/d4ra04748f. eCollection 2024 Oct 23.
7
Rutin-Loaded Transethosomal Gel for Topical Application: A Comprehensive Analysis of Skin Permeation and Antimicrobial Efficacy.用于局部应用的芦丁负载转质体凝胶:皮肤渗透和抗菌功效的综合分析
ACS Omega. 2024 Jun 10;9(25):27300-27311. doi: 10.1021/acsomega.4c01718. eCollection 2024 Jun 25.
8
Statins-Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers.他汀类药物 - 它们在骨组织代谢中的作用及其与不同载体的局部应用。
Int J Mol Sci. 2024 Feb 17;25(4):2378. doi: 10.3390/ijms25042378.
9
A personalized biomimetic dual-drug delivery system via controlled release of PTH and simvastatin for osteoporotic bone regeneration.一种通过控制甲状旁腺激素(PTH)和辛伐他汀的释放实现骨质疏松性骨再生的个性化仿生双药递送系统。
Front Bioeng Biotechnol. 2024 Jan 31;12:1355019. doi: 10.3389/fbioe.2024.1355019. eCollection 2024.
10
SARS-CoV-2 Papain-like Protease Responsive ZnO/Daclatasvir-Loaded Chitosan/Gelatin Nanofibers as Smart Antimicrobial Medical Textiles: In Silico, In Vitro and Cell Studies.SARS-CoV-2木瓜样蛋白酶响应性负载齐多夫定/达卡他韦的壳聚糖/明胶纳米纤维作为智能抗菌医用纺织品:计算机模拟、体外和细胞研究
Pharmaceutics. 2023 Aug 2;15(8):2074. doi: 10.3390/pharmaceutics15082074.